Cargando…
Desmopressin Lyophilisate for the Treatment of Central Diabetes Insipidus: First Experience in Very Young Infants
INTRODUCTION: In neonates and small infants, early diagnosis of central diabetes insipidus (CDI) and treatment with desmopressin in low doses (avoiding severe hypo- or hypernatremia) are important to prevent associated high morbidity and mortality in this particular age group. CASE PRESENTATION: We...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4338649/ https://www.ncbi.nlm.nih.gov/pubmed/25745483 http://dx.doi.org/10.5812/ijem.16120 |
_version_ | 1782481244930441216 |
---|---|
author | De Waele, Kathleen Cools, Martine De Guchtenaere, Ann Van de Walle, Johan Raes, Ann Van Aken, Sara De Coen, Kris Vanhaesebrouck, Piet De Schepper, Jean |
author_facet | De Waele, Kathleen Cools, Martine De Guchtenaere, Ann Van de Walle, Johan Raes, Ann Van Aken, Sara De Coen, Kris Vanhaesebrouck, Piet De Schepper, Jean |
author_sort | De Waele, Kathleen |
collection | PubMed |
description | INTRODUCTION: In neonates and small infants, early diagnosis of central diabetes insipidus (CDI) and treatment with desmopressin in low doses (avoiding severe hypo- or hypernatremia) are important to prevent associated high morbidity and mortality in this particular age group. CASE PRESENTATION: We described pharmacokinetic and pharmacodynamic results of the use of recently launched oral desmopressin lyophilisate (Minirin Melt®) in two infants with CDI, diagnosed at the age of 12 and 62 days, respectively. We observed that a starting dose of 60 μg of Minirin Melt® in the first case resulted in a pharmacokinetic profile largely exceeding the reference frame observed in children with nocturnal enuresis, while a dose of 15 μg in the second case resulted in acceptable concentrations. After initial dose adjustments, administration of sublingual lyophilisate resulted in rather stable serum sodium concentrations. CONCLUSIONS: Using Minirin Melt® in infants with CDI appears to be effective, easy to use and well tolerated. |
format | Online Article Text |
id | pubmed-4338649 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Kowsar |
record_format | MEDLINE/PubMed |
spelling | pubmed-43386492015-03-05 Desmopressin Lyophilisate for the Treatment of Central Diabetes Insipidus: First Experience in Very Young Infants De Waele, Kathleen Cools, Martine De Guchtenaere, Ann Van de Walle, Johan Raes, Ann Van Aken, Sara De Coen, Kris Vanhaesebrouck, Piet De Schepper, Jean Int J Endocrinol Metab Case Report INTRODUCTION: In neonates and small infants, early diagnosis of central diabetes insipidus (CDI) and treatment with desmopressin in low doses (avoiding severe hypo- or hypernatremia) are important to prevent associated high morbidity and mortality in this particular age group. CASE PRESENTATION: We described pharmacokinetic and pharmacodynamic results of the use of recently launched oral desmopressin lyophilisate (Minirin Melt®) in two infants with CDI, diagnosed at the age of 12 and 62 days, respectively. We observed that a starting dose of 60 μg of Minirin Melt® in the first case resulted in a pharmacokinetic profile largely exceeding the reference frame observed in children with nocturnal enuresis, while a dose of 15 μg in the second case resulted in acceptable concentrations. After initial dose adjustments, administration of sublingual lyophilisate resulted in rather stable serum sodium concentrations. CONCLUSIONS: Using Minirin Melt® in infants with CDI appears to be effective, easy to use and well tolerated. Kowsar 2014-10-01 /pmc/articles/PMC4338649/ /pubmed/25745483 http://dx.doi.org/10.5812/ijem.16120 Text en Copyright © 2014, Research Institute For Endocrine Sciences and Iran Endocrine Society; Published by Kowsar Corp. http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report De Waele, Kathleen Cools, Martine De Guchtenaere, Ann Van de Walle, Johan Raes, Ann Van Aken, Sara De Coen, Kris Vanhaesebrouck, Piet De Schepper, Jean Desmopressin Lyophilisate for the Treatment of Central Diabetes Insipidus: First Experience in Very Young Infants |
title | Desmopressin Lyophilisate for the Treatment of Central Diabetes Insipidus: First Experience in Very Young Infants |
title_full | Desmopressin Lyophilisate for the Treatment of Central Diabetes Insipidus: First Experience in Very Young Infants |
title_fullStr | Desmopressin Lyophilisate for the Treatment of Central Diabetes Insipidus: First Experience in Very Young Infants |
title_full_unstemmed | Desmopressin Lyophilisate for the Treatment of Central Diabetes Insipidus: First Experience in Very Young Infants |
title_short | Desmopressin Lyophilisate for the Treatment of Central Diabetes Insipidus: First Experience in Very Young Infants |
title_sort | desmopressin lyophilisate for the treatment of central diabetes insipidus: first experience in very young infants |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4338649/ https://www.ncbi.nlm.nih.gov/pubmed/25745483 http://dx.doi.org/10.5812/ijem.16120 |
work_keys_str_mv | AT dewaelekathleen desmopressinlyophilisateforthetreatmentofcentraldiabetesinsipidusfirstexperienceinveryyounginfants AT coolsmartine desmopressinlyophilisateforthetreatmentofcentraldiabetesinsipidusfirstexperienceinveryyounginfants AT deguchtenaereann desmopressinlyophilisateforthetreatmentofcentraldiabetesinsipidusfirstexperienceinveryyounginfants AT vandewallejohan desmopressinlyophilisateforthetreatmentofcentraldiabetesinsipidusfirstexperienceinveryyounginfants AT raesann desmopressinlyophilisateforthetreatmentofcentraldiabetesinsipidusfirstexperienceinveryyounginfants AT vanakensara desmopressinlyophilisateforthetreatmentofcentraldiabetesinsipidusfirstexperienceinveryyounginfants AT decoenkris desmopressinlyophilisateforthetreatmentofcentraldiabetesinsipidusfirstexperienceinveryyounginfants AT vanhaesebrouckpiet desmopressinlyophilisateforthetreatmentofcentraldiabetesinsipidusfirstexperienceinveryyounginfants AT deschepperjean desmopressinlyophilisateforthetreatmentofcentraldiabetesinsipidusfirstexperienceinveryyounginfants |